These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35604672)

  • 1. Restoration of Vision and Retinal Responses After Adeno-Associated Virus-Mediated Optogenetic Therapy in Blind Dogs.
    Nikonov S; Aravand P; Lyubarsky A; Nikonov R; Luo AJ; Wei Z; Maguire AM; Phelps NT; Shpylchak I; Willett K; Aleman TS; Huckfeldt RM; Ramachandran PS; Bennett J
    Transl Vis Sci Technol; 2022 May; 11(5):24. PubMed ID: 35604672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optogenetic Strategies for Vision Restoration.
    Lu Q; Pan ZH
    Adv Exp Med Biol; 2021; 1293():545-555. PubMed ID: 33398841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degenerated Cones in Cultured Human Retinas Can Successfully Be Optogenetically Reactivated.
    Kamar S; Howlett MHC; Klooster J; Graaff W; Csikós T; Rabelink MJWE; Hoeben RC; Kamermans M
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mini-Review: Cell Type-Specific Optogenetic Vision Restoration Approaches.
    Chaffiol A; Duebel J
    Adv Exp Med Biol; 2018; 1074():69-73. PubMed ID: 29721929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optogenetic Therapy for Visual Restoration.
    Sakai D; Tomita H; Maeda A
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optogenetic approaches to therapy for inherited retinal degenerations.
    De Silva SR; Moore AT
    J Physiol; 2022 Nov; 600(21):4623-4632. PubMed ID: 35908243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-Characteristic Opsin Therapy to Functionalize Retina, Attenuate Retinal Degeneration, and Restore Vision in Mouse Models of Retinitis Pigmentosa.
    Batabyal S; Kim S; Carlson M; Narcisse D; Tchedre K; Dibas A; Sharif NA; Mohanty S
    Transl Vis Sci Technol; 2024 Oct; 13(10):25. PubMed ID: 39412768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy.
    Kralik J; Kleinlogel S
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina.
    Chaffiol A; Caplette R; Jaillard C; Brazhnikova E; Desrosiers M; Dubus E; Duhamel L; Macé E; Marre O; Benoit P; Hantraye P; Bemelmans AP; Bamberg E; Duebel J; Sahel JA; Picaud S; Dalkara D
    Mol Ther; 2017 Nov; 25(11):2546-2560. PubMed ID: 28807567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of high-sensitivity and adapting vision with a cone opsin.
    Berry MH; Holt A; Salari A; Veit J; Visel M; Levitz J; Aghi K; Gaub BM; Sivyer B; Flannery JG; Isacoff EY
    Nat Commun; 2019 Mar; 10(1):1221. PubMed ID: 30874546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional characteristics of optogenetic gene therapy for vision restoration.
    Lindner M; Gilhooley MJ; Peirson SN; Hughes S; Hankins MW
    Cell Mol Life Sci; 2021 Feb; 78(4):1597-1613. PubMed ID: 32728765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust cone-mediated signaling persists late into rod photoreceptor degeneration.
    Scalabrino ML; Thapa M; Chew LA; Zhang E; Xu J; Sampath AP; Chen J; Field GD
    Elife; 2022 Aug; 11():. PubMed ID: 36040015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Ophthalmic Optogenetics: Approaches and Applications.
    Prosseda PP; Tran M; Kowal T; Wang B; Sun Y
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cone-Driven, Geniculocortical Responses in Canine Models of Outer Retinal Disease.
    Taskin HO; Wivel J; Aguirre GD; Beltran WA; Aguirre GK
    Transl Vis Sci Technol; 2024 Jan; 13(1):18. PubMed ID: 38241039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa.
    Xue Y; Wang SK; Rana P; West ER; Hong CM; Feng H; Wu DM; Cepko CL
    Elife; 2021 Apr; 10():. PubMed ID: 33847261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapy.
    De Silva SR; Barnard AR; Hughes S; Tam SKE; Martin C; Singh MS; Barnea-Cramer AO; McClements ME; During MJ; Peirson SN; Hankins MW; MacLaren RE
    Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11211-11216. PubMed ID: 28973921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
    Rolling F; Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
    Bull Mem Acad R Med Belg; 2006; 161(10-12):497-508; discussion 508-9. PubMed ID: 17503728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optogenetics for visual restoration: From proof of principle to translational challenges.
    Lindner M; Gilhooley MJ; Hughes S; Hankins MW
    Prog Retin Eye Res; 2022 Nov; 91():101089. PubMed ID: 35691861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV Restores ON and OFF visual responses in blind mice.
    Macé E; Caplette R; Marre O; Sengupta A; Chaffiol A; Barbe P; Desrosiers M; Bamberg E; Sahel JA; Picaud S; Duebel J; Dalkara D
    Mol Ther; 2015 Jan; 23(1):7-16. PubMed ID: 25095892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV-mediated Gene Therapy Halts Retinal Degeneration in PDE6β-deficient Dogs.
    Pichard V; Provost N; Mendes-Madeira A; Libeau L; Hulin P; Tshilenge KT; Biget M; Ameline B; Deschamps JY; Weber M; Le Meur G; Colle MA; Moullier P; Rolling F
    Mol Ther; 2016 May; 24(5):867-76. PubMed ID: 26857842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.